Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™

This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately.

MammoScreen at the RSNA 2020 annual meeting – Virtual Radiology Conference

Visit our digital booth to learn more about MammoScreen™, an AI proficiency tool

Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health

The collaboration donates and supports AI for making breast cancer screening more accessible and available in impoverished regions of the world

Operations for MammoScreen by Therapixel are now ISO/IEC 27001 certified

Our information security management system is compliant with the world gold standard, ensuring a high level of cybersecurity.

MammoScreen is FDA-cleared and available for sale in the US

AI-powered reading aid for screening mammography improves Radiologists’ performance in cancer detection

Sign up for News & Updates